Conference Description:

WELCOME REMARK

The organizing committee sincerely welcome you to join in The 4th SYMPOSIUM ON WORLD CANCER RESEARCH (SWCR 2024), which will be held during Apr.22nd-24th, 2024 in Singapore.

SWCR 2024 includes plenary forum, 15 breakout streams, as well as poster exhibition in the three-day scientific program. The topics will focus on Cancer Genetics and Genomics, Cancer Screening and Early Detection, Cancer Therapy and Treatment, Cancer Metastasis, Tumor Microenvironment and different kinds of cancers/tumors, such as Lung Caner, Breast Cancer, etc.

SWCR 2024 is planned as a hybrid event. We are hopeful that many of you will be able to make the trip to the beautiful country to see old colleagues, and make new friends.

Website: https://swcr2024.lmsii.org/; https://swcr2024.vowcongress.cn/

Contact us: Ms. Lucy Hsieh Email: [email protected]

Topics:
Cancer Genetics and Genomics;
Cancer Biomarker and Diagnosis;
Immunology and Immunotherapy;
Prostate and Bladder Cancers;
New Therapeutics and Targets;
Tumor Microenvironment;
Breast Cancer;
Cancer Metastasis

Renowned Speakers of SWCR 2024

Prof. Iris Barshack, Sheba Medical Center, Israel;
Dr. Olivier Pardo, Imperial College London, UK;
Dr. Junichi Taguchi, Tokyo Midtown Clinic, Japan;
Prof. Angus G Dalgleish, St George’s University of London, UK;
Dr. Alessandra Longhi, Istituto Ortopedico Rizzoli Bologna, Italy;
Dr. Arul Earnest, Monash University, Australia



Schedule of SWCR & CMB & PSCR 2024
Based upon GMT+8, Singapore Time

Apr. 22, 2024 (Monday)
8:30-12:00
CMB Hybrid Session: Genetics & Genomics
CMB Hybrid Session: Protein, Peptide and Proteomics
SWCR Hybrid Session: Case Studies/Clinical Experience
13:30-18:30
SWCR Hybrid Session: Cancer Biomarker and Diagnosis
SWCR Hybrid Session: Cancer Genetics and Genomics
CMB Hybrid Session: Breaking Research in Cell Biology
CMB Hybrid Session: Molecular Diagnostics & Biomarkers
20:30-22:00
SWCR Online Session: Plenary Forum of SWCR

Apr. 23, 2024 (Tuesday)
8:30-12:00
PSCR Hybrid Session: Cancers and Tumors
SWCR Hybrid Session: Cancer Cell and Molecular Biology
SWCR Hybrid Session: Tumor Microenvironment
CMB Hybrid Session: Signaling Pathways and Therapeutic Targets
13:30-18:30
PSCR Hybrid Session: Plenary Forum of PSCR
CMB Hybrid Session: Advances in DNA & RNA Research
SWCR Hybrid Session: New Therapeutics and Targets
SWCR Hybrid Session: Liver Cancer and Pancreatic Cancers
20:30-22:00
SWCR Online Session: Cancer Informatics and Precision Oncology

Apr. 24, 2024 (Wednesday)
8:30-12:00
SWCR Hybrid Session: Cancer Therapy and Treatment (Part 1)
PSCR Hybrid Session: Antibody and Vaccines
13:30-18:30
SWCR Hybrid Session: Lung Cancer
SWCR Hybrid Session: Immunology and Immunotherapy
CMB Hybrid Session: Biomaterials and Biological Engineering
PSCR Hybrid Session: Metabolic and Endocrine Disorders
20:30 -22:00
SWCR Online Session: Cancer Therapy and Treatment (Part 2)


Apr. 25, 2024 (Thursday)
8:30-12:00
PSCR Hybrid Session: Small Molecule Antagonists and Agonists
PSCR Hybrid Session: Infectious Diseases
PSCR Hybrid Session: Natural Products and Traditional Therapy
13:30-18:30
PSCR Hybrid Session: Inflammation and Immunology
PSCR Hybrid Session: Pharmacology and Pharmacogenomics
PSCR Hybrid Session: Pharmaceutics and Drug Delivery
PSCR Hybrid Session: Pharmaceutical Biology and Medical Chemistry